Capital Flow Monitor · Sponsors · CIK 2129660
SONIRE Therapeutics Inc.
214 HOMER AVE, PALO ALTO, CA, 94301 · (650)460-9879
Other Health Care · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$13.5M
Sold
$13.5M
% sold
100.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | D ·current | 506(b) | $13.5M | $13.5M | 100.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Tohru Satoh — Executive Officer / Director / Promoter, Palo Alto, CA
- Koji Yasuda — Director, Tokyo, M0
- Jun Okamoto — Director, Tokyo, M0
- Auriel August — Director, Austin, TX
-
Dennis McWilliams — Director, Austin, TX
2 other raises
- Surgical Safety Technologies Inc. $18.2M of $20.2M · 90.1%
- Apreo Health, Inc. $81.8M of $130.6M · 62.7%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.